Description
The Department of Veterans Affairs is conducting market research to identify parties interested in providing non-invasive urine testing for prostate cancer. The test should provide a risk score to help differentiate patients with high and low risk of aggressive prostate cancer. The vendor should ship test kits directly to patients with a prepaid return label to the vendor's testing facility. The applicable NAICS code is 621511 (Medical Laboratories).
• The test risk score should be based on an analysis of RNA markers and should not incorporate PSA levels in its algorithm.
• The vendor should not require the DRE (digital rectal exam) prior to collection of the urine specimen.
• The vendor should provide test kits to the laboratory department for distribution to designated patients with a prepaid return label to the vendor's testing facility.
• The government assumes no financial responsibility for any costs incurred in response to this market survey.